- The 8 States Most Likely to Legalize Marijuana Next
- Behind Russia's Current Crisis: It's Not the Ruble, It's Putin
- Would you invest in the U.S. Postal Service?
- Why Jim Cramer Says it Could be Too Late to Enter the Stock Market Rally Now
- Apple (AAPL) Stock Declining Today Amid Allegations of Poor Working Conditions in China
Be careful, though - the company's mergers and partnerships come with risk.
The focus was on new drugs under development and bringing them to market.
Goldman upgrades the early recovery plays; also, gauging Chinese growth and the swine flu effect on pork producers.
Expect a lively Q&A as management finesses the robust pipeline prospects in the face of coming generic exposure.
The stock's impressive rebound makes investors look well into the next decade to justify further gains.